Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists at TSRI identify thousands of proteins associated with deadliest form of malaria

04.10.2002


Two scientists at The Scripps Research Institute (TSRI) led a collaborative effort involving 18 researchers at half a dozen laboratories in the United States and Great Britain to determine the "proteome" of the most deadly form of the malaria pathogen - Plasmodium falciparum.

This study, in the current issue of the journal Nature, accompanies an article detailing the completion of a major six-year $17.9-million genome-sequencing effort involving 185 researchers from the United Kingdom, the United States, and Australia that sequenced the entire Plasmodium falciparum genome.

"This is the first instance that I know of where these proteomics studies have gone along side-by-side with the genome sequencing project," says TSRI Cell Biology Professor John Yates, Ph.D, who was the lead scientist involved in the proteomics effort, which identified the proteins in the single-celled Plasmodium that cause malaria.



These efforts will pay huge dividends in global healthcare if even a few of the newly identified proteins lead to the development of new malaria vaccines--and Yates and his colleagues found a total of more than 2,400 proteins.

"We don’t exactly know the function of well over half of the proteins identified--we just know that they are there," says Laurence Florens, Ph.D., who is a research associate at TSRI and the lead author of the study.

Malaria is a nasty and often fatal disease, which may lead to kidney failure, seizures, permanent neurological damage, coma, and death. There are four types of Plasmodium parasites that cause the disease, of which falciparum is the most deadly. (See Supplemental Information: Malaria.)

Knowing which proteins are expressed by Plasmodium falciparum should help scientists understand how the pathogen causes malaria and, with luck, how to thwart it. That was the goal of the proteomics approach taken by Florens and Yates.

Where "genomics" maps the DNA sequence and genes in an organism like Plasmodium falciparum, "proteomics" adds the topographical information to that map by identifying which genes are actually expressed as proteins in the Plasmodium falciparum cells.

More importantly, Florens and Yates also sought to identify which proteins are expressed at which stages of the organism’s lifecycle. This was no small task. Plasmodium falciparum has at least ten distinct stages in its lifecycle, and there is no way of telling which are expressed at each distinct stage of the pathogen’s lifecycle simply by looking at the genes.

But Florens and Yates were able to figure out which proteins were expressed during four different stages (sporozoites, merozoites, trophozoites, and gametocytes) and, thus, which might make good vaccine targets.

Mass Spectrometry and Malaria

The process was basically to take samples of a single isolate of Plasmodium falciparum and grow three of the four different stages in blood in a way that allowed samples to be purified. The fourth stage, the sporozoites, had to be hand-dissected from mosquito salivary glands.

In purifying the samples, Yates and Florens first separated the soluble proteins from the membrane-bound proteins, then digested them (chopped into smaller "peptide" pieces with enzymes), and resolved them using liquid chromatography combined with tandem mass spectrometry.

The instrument detects the pieces and uses sophisticated software that Yates and his colleagues developed previously to search a database of predicted genes to reconstruct most of the proteins in the sample. This technique was particularly useful in this context because it allowed a very large background "noise" of mosquito and human proteins to be subtracted out. The peptides that come from the Plasmodium can be distinguished from those that come from the mosquito or the human.

Furthermore, using the technique, Florens and Yates were able to show not only which genes were expressed in each stage of the Plasmodium falciparum life cycle, but which proteins were membrane-associated, and which were inside the cell--important pieces of information for vaccine design.

One unexpected finding was that a lot of the proteins that were expressed in particular stages "co-localized" in chromosomal gene clusters possibly under the control of common regulatory elements.

Promoters are regions of DNA in front of a gene that "turn on" that gene like a switch and cause it to be expressed as protein. Normally, any given gene will have its own promoter. But Florens and Yates found many different clusters of genes that become expressed together and might be under the control of a single promoter. Florens and Yates believe that this is one of the ways that the pathogen is able to thrive in two different organisms (mosquitoes and humans).

"The switching between stages is something that happens very fast," says Florens, "and [the pathogen] needs a mechanism to express many genes quickly."

Keith McKeown | EurekAlert!
Further information:
http://www.scripps.edu/

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

How algae and carbon fibers could sustainably reduce the athmospheric carbon dioxide concentration

14.11.2018 | Life Sciences

NIH scientists illuminate causes of hepatitis b virus-associated acute liver failure

14.11.2018 | Life Sciences

The unintended consequences of dams and reservoirs

14.11.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>